This inventor holds 1 USPTO granted patent. Top assignee: Accuredit Therapeutics (Suzhou) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Feifei Duan: Innovator in Base Editing Technologies
Introduction
Feifei Duan is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of genetic engineering, particularly in the area of base editing technologies. His work focuses on developing innovative tools that can modify nucleobase sequences with precision.
Latest Patents
Feifei Duan holds a patent for "Deaminases and variants thereof for use in base editing." This patent includes adenosine deaminases and their variants, nucleobase editors that comprise these deaminases, compositions that include such editors, and methods for using these editors to generate modifications in target nucleobase sequences. This invention represents a significant advancement in the ability to edit genetic material.
Career Highlights
Feifei Duan is currently employed at Accuredit Therapeutics (Suzhou) Co., Ltd. His role at the company allows him to further his research and development efforts in the field of genetic editing. His innovative work has positioned him as a key figure in the biotechnology sector.
Collaborations
Feifei Duan collaborates with notable colleagues, including Pengfei Hu and Han Qiu. These partnerships enhance the research and development efforts at Accuredit Therapeutics, fostering an environment of innovation and discovery.
Conclusion
Feifei Duan's contributions to base editing technologies exemplify the impact of innovative research in biotechnology. His patent and ongoing work at Accuredit Therapeutics highlight the importance of advancements in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile